Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

September 20, 2018

Study Completion Date

December 26, 2018

Conditions
Epidermal Growth FactorNd-yttrium Aluminum Garnet LaserHyperpigmentationPost Inflammatory Hyperpigmentation
Interventions
DRUG

epidermal growth factor (EGF)-containing ointment

The subjects applied the epidermal growth factor (EGF) ointment twice daily (morning and evening) to the lesion for 4 weeks after laser treatment.

DRUG

Vehicle ointment

To compare the effect of epidermal growth factor (EGF) ointment, the control subjects applied the vehicle ointment twice daily (morning and evening) to the lesion for 4 weeks after laser treatment.

PROCEDURE

Q-swithced (QS) 532-nm Nd:yttrium aluminum garnet (YAG) laser

"The subjects received one session of laser treatment with a Q-swithced (QS) 532-nm Nd:yttrium aluminum garnet (YAG) laser of their solar lentigines after enrollment.~The procedure parameters were as follows: 5-10-ns pulse duration, 3.5-mm spot size, 0.9-1.1-J/cm2 fluence, and 2-Hz frequency.~The end point of laser treatment for lentigines was immediate whitening."

Trial Locations (1)

Unknown

Kangnam Sacred Heart Hospital, Seoul

All Listed Sponsors
lead

Hallym University Kangnam Sacred Heart Hospital

OTHER

NCT04704245 - Effectiveness of Epidermal Growth Factor-containing Ointment on the Solar Lentigines | Biotech Hunter | Biotech Hunter